LBEPA09	Recombination of “defective” proviruses to produce replication-competent HIV-1	E-poster	HIV virology
EPB0278	Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in persons living with HIV (PLWH): safety and immunogenicity analysis	E-poster	SARS-CoV-2, COVID-19 and HIV
EPB0279	Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) (Ad5-nCoV) in persons living with HIV (PLWH): Immunogenicity comparative analysis between one dose and two doses of Ad5-nCoV vaccine	E-poster	SARS-CoV-2, COVID-19 and HIV
EPC0334	Recent HIV outbreaks in Japan originated from late presenters: Implementation of molecular transmission network analysis	E-poster	Surveillance: Measuring the HIV epidemic
EPC0326	Recent HIV diagnosis in Thai population at Anonymous Clinic, Thai Red Cross AIDS Research Centre, Bangkok, Thailand	E-poster	Surveillance: Measuring the HIV epidemic
EPB0223	Real-world utilization and effectiveness of long-acting cabotegravir+rilpivirine in the United States: Trio Cohort study	E-poster	Antiretroviral therapies and clinical issues in adults
EPB0209	Real-world observational study in Europe on the effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor (COMBINE-2): week 96 stable switch population results	E-poster	Antiretroviral therapies and clinical issues in adults
EPC0397	Real-world effectiveness of HIV pre-exposure prophylaxis in key and priority populations receiving HIV services from private-not-for-profit health facilities in Uganda: a retrospective cohort study	E-poster	HIV prevention research
EPC0397	Real-world effectiveness of HIV pre-exposure prophylaxis in key and priority populations receiving HIV services from private-not-for-profit health facilities in Uganda: a retrospective cohort study	E-poster	HIV prevention research
EPB0155	Readiness for HCV care provision for men who have sex with men in seven countries	E-poster	Co-infections (including opportunistic infections)